To assess reproducibility, we produced a SOP for the assay and a qualification plan, and measured CD4+ T-cell responses to PI33-63 and tetanus toxoid from cryopreserved PBMC of a single patient diagnosed with T1D ≤ 3 months. This evidence concerns the gene CD4 and type 1 diabetes mellitus.